A plastic and aesthetic surgery clinic came to DGS in 2024 with a focused brief: win the United States. The clinic was treating around 40 US patients a month; the American market’s demand for high-quality, transparently priced aesthetic surgery abroad was obvious, but converting it required more than campaigns. Today the clinic books 320+ US patients a month — an 8× increase from a single, deliberately targeted market program.
The starting point
US patients are the most research-intensive buyers in medical travel: they compare surgeons’ credentials, demand itemised pricing, read every review, and expect responses in minutes, in fluent English, in their own time zone. The clinic’s existing funnel — built for closer markets — was losing American inquiries at every one of those points.
What DGS operated
We rebuilt the funnel specifically for the American buyer. Demand generation combined US-focused search, AI-answer optimisation and paid campaigns built around the questions US patients actually ask — surgeon credentials, safety standards, itemised costs versus US prices, and recovery logistics. Landing pages led with accreditation and transparent pricing. A native-fluency telesales desk covered US hours, with response-time SLAs measured in minutes, and the CRM carried every case from first inquiry through travel, surgery and structured aftercare follow-up.
The results
Monthly US patient volume grew from 40 to 320+ within the program — an annualised run-rate rising from roughly 480 to more than 3,800 patients. Growth held as spend scaled because conversion, not just traffic, was engineered: the same demand that once leaked now books.
Why it worked
Single-market depth beats multi-market spread when the market is the United States. By building the entire journey around one buyer profile — their questions, their hours, their trust thresholds — the clinic turned the world’s most demanding patients into its largest source of growth.